Status:
COMPLETED
Seroprevalence of Infection-induced SARS-CoV-2 Antibodies (COVID-19) in Children
Lead Sponsor:
National Children's Hospital, Vietnam
Conditions:
COVID-19
Eligibility:
All Genders
Up to 18 years
Brief Summary
It is unknown what proportion of children have been exposed to SARS-CoV-2 and how many have antibodies among children seeking medical care for non-Covid-19 related conditions. The aim of this study i...
Detailed Description
Enrolled participants will have a survey about demographic information, history of previous suspected/confirmed Covid-19 infection or exposed to SARS-CoV-2, Covid-19 vaccination status. For participan...
Eligibility Criteria
Inclusion
- Age ≤ 18 years old.
- Seeking medical care at Vietnam National Children's Hospital for any condition not related to acute Covid-19
- Have not been previously diagnosed and are presumed/confirmed COVID-19 negative
- Have blood specimens collected for any routine biochemistry test on the date enrollment
Exclusion
- Refusal to participate in this study.
Key Trial Info
Start Date :
March 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 13 2022
Estimated Enrollment :
4032 Patients enrolled
Trial Details
Trial ID
NCT05358626
Start Date
March 13 2022
End Date
November 13 2022
Last Update
March 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vietnam National Children's Hospital
Hanoi, Vietnam